BioElectronics Announces Major Clini...(rative procedures to assist patients inp...),Health

About BioElectronics Corporation

BioElectronics Corporation is the maker of the ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for about a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective patient friendly method to reduce soft tissue pain and swelling. ActiPatch is approved by Health Canada for the relief of pain in musculoskeletal complaints. The US government's food and drug administration (FDA) has cleared the use of the product for reducing edema (swelling) following blepharoplasty and the European Union has approved the product as a class two pulsed electromagnetic medical device as have numerous other international record for agencies.

About David G. Genecov, MD FACS FAAP

Dr. David G. Genecov is a native of Dallas, Texas. After finishing his undergraduate degree in the Plan II Honors Program at the University of Texas, he completed his medical training at the University of Texas Health Science Center in San Antonio. Upon completion of his general surgery residency at West Virginia University, Dr. Genecov became board certified in general surgery. He continued his education at Wake Forest University - Bowman Gray School of Medicine and completed his plastic surgery residency. He then completed a fellowship at the International Craniofacial Institute, Dallas, Texas, in Craniomaxillofacial surgery for adults and children with congenital and acquired deformities.

Widely published in both national and international literature, Dr. Genecov has also authored four medical book chapters. Dr. Genecov has received numerous awards for academic excellence, his surgical expertise and philanthropy. Most recently he was named one of the country's top surgeons by the independent Consumer Research Council of Am
'/>"/>